Navigation Links
The Ross Summit to focus on new survival data, technique refinement and availability

ATLANTA, GA (October 12, 2010) More than 100 cardiovascular surgeons and cardiologists from 25 countries are scheduled to attend the third annual global Ross Summit, a two-day surgical congress focused on the Ross Procedure. Filled with a number of point-counterpoint discussions, the forum will feature the presentation of much new data about the Ross Procedure and interactive discussions among many of the world's elite cardiovascular surgeons and cardiologists regarding survival, quality of life, technique refinement and availability of the procedure to the patients who best benefit from it.

CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, will convene the summit at its corporate headquarters training facility in suburban Atlanta Oct. 15 and 16.

"Currently, the Ross Procedure is performed on about 1,500 individuals globally each year. Perhaps the most important advantage of the procedure is growing evidence of improved long-term survival and quality of life over other valve replacement options," said Dr. William Northrup III, vice president of physician relations and education at CryoLife. "The procedure is also attractive because patients who undergo the procedure do not have to take long-term anticoagulant medications after surgery and experience no restrictions in physical activity. Historically, there has been much discussion regarding the survival data and the impact of patient selection on the data. The Ross Summit always provides a balanced opportunity for interactive discussion after each presentation. Of particular interest this year will be presentations and discussions surrounding data for patients into the second decade following their Ross Procedure."

Pioneered in 1967, the Ross Procedure is a type of specialized aortic valve surgery in which the patient's diseased aortic valve is replaced with his or her own pulmonary valve. The pulmonary valve is then typically replaced with a cryopreserved human pulmonary valve. The procedure is a complex surgical technique that is usually performed in specialized centers by surgeons who have developed specific expertise with the procedure. As a result, one of the Summit's sessions will focus on increasing the availability of the procedure to the patients for whom it is best suited by increasing awareness in the cardiologist community and by mentoring the next generation of Ross surgeons.

Led by Professor Sir Magdi Yacoub, FRS, FRCS, of Imperial College's Heart Science Center in London in tandem with Dr. Northrup, The Ross Summit also includes two afternoons of hands-on mentored instruction in the various techniques of this specific form of cardiac reconstruction utilizing biological simulators. A full faculty list and summit agenda can be found at

"Things are constantly changing, evolving and improving within the Ross Procedure community," noted Steven G. Anderson, chairman, president and CEO of CryoLife. "It's why CryoLife hosts the Ross Summit annually. The interaction and perspective from peers and the continued sharing of new data have proven valuable to this elite group of cardiothoracic surgeons as evidenced by the repeat registrations each year."

A decellularized human pulmonary heart valve, CryoValve SG, processed using CryoLife's SynerGraft technology, was cleared by the FDA in February 2008 for use in cardiac reconstruction procedures such as the Ross Procedure.


Contact: Dana Hartline
Edelman PR

Related medicine news :

1. Mayo Clinic Sports Medicine to host concussion summit
2. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
3. UN Summit launches drive to save lives of more than 16 million women and children
4. 2010 Resource Planning Summit to offer $695 Registration Fee for PDMA, PMI, BIOCOM and ASAPM Members
5. Cambridge Healthtech Institute Announces its Second Annual "The Bioprocessing Summit"
6. IAS urges donors to maintain commitment to global HIV response ahead of the G8 Summit
7. Summit Credit Union Delivers Random Acts of Kindness; Introducing the DoMore Team
8. MedStar Hospitals Honored at Obstetric Care Conference: The Third Annual PeriGen Knowledge Summit
9. Summit Health, U.S. Preventive Medicine Agree to Continue Worksite Screening Partnership
10. Lenox Hill Hospital Honored at Obstetric Care Conference: The Third Annual PeriGen Knowledge Summit
11. SIUE Pain Summit Recommendations Announced Today
Post Your Comments:
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: